Showing results (1-10 of 265) with videos related to
Sort By:
Pageof 27
La Revue Du Praticien|October 22, 1998
[Regulation of phosphatemia and hypophosphatemia]M Essig, G FriedlanderTherapie|June 22, 2000
[Inhibitors of HMG CoA reductase: new modes of action, new indications?]M Essig, F Vrtovsnik, G FriedlanderPresse Medicale (Paris, France : 1983)|May 19, 2000
[Growth factors. Role in the progression of renal lesions]F Terzi, M Burtin, M Essig, et al.Kidney International. Supplement|July 21, 1999
Effect of lipid-lowering strategies on tubular cell biologyF Vrtovsnik, M Essig, O Iimura, et al.American Journal of Physiology. Renal Physiology|September 13, 2001
Mechanical strains induced by tubular flow affect the phenotype of proximal tubular cellsM Essig, F Terzi, M Burtin, et al.Journal of the American Society of Nephrology : JASN|August 11, 1998
Lovastatin modulates in vivo and in vitro the plasminogen activator/plasmin system of rat proximal tubular cells: role of geranylgeranylation and Rho proteinsM Essig, F Vrtovsnik, G Nguyen, et al.Journal of the American Society of Nephrology : JASN|June 30, 1998
Dipyridamole decreases renal phosphate leak and augments serum phosphorus in patients with low renal phosphate thresholdD Prié, F B Blanchet, M Essig, et al.Circulation Research|October 3, 1998
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteinsM Essig, G Nguyen, D Prié, et al.Circulation Research|March 9, 2002
Lovastatin enhances ecto-5'-nucleotidase activity and cell surface expression in endothelial cells: implication of rho-family GTPasesS Ledoux, D Laouari, M Essig, et al.Pageof 27